The Epidermal Growth Factor Receptor (EGFR) has previously been identified to be directly regulated by miR-218 in non-small cell lung cancer in vitro and in vivo (Zhu et al. 2016) and glioblastoma in vitro (Mathew et al. 2015), and a subsequent study has been able to establish links to therapy resistance (Jin et al. 2020). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.